Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.46 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11759259 | 0.82 | NPC1 (0.37) | NPC1ALDH1A1MAPTGFERHSD17B10 | |
| SCHEMBL2432241 | 0.80 | FBP1 (0.68) | FBP1PDE7ANPC1ALDH1A1MAPT | |
| SCHEMBL27926446 | 0.78 | FBP1 (0.41) | FBP1PDE7ANPC1ALDH1A1MAPT | |
| SCHEMBL2786209 | 0.76 | FBP1 (0.46) | FBP1PDE7ANPC1RAB9A | |
| SCHEMBL19058869 | 0.76 | FBP1 (0.46) | FBP1PDE7ANPC1RAB9A | |
| SCHEMBL2786831 | 0.76 | FBP1 (0.42) | FBP1PDE7ANPC1HSD17B10KDM4E | |
| SCHEMBL2786988 | 0.76 | FBP1 (0.42) | FBP1PDE7APTGS2 | |
| SCHEMBL2786543 | 0.76 | FBP1 (0.42) | FBP1PDE7A | |
| SCHEMBL2786198 | 0.73 | LMNA (0.54) | FBP1NPC1ALDH1A1MAPTHSD17B10 | |
| SCHEMBL19259968 | 0.73 | FBP1 (0.39) | FBP1PDE7AALDH1A1HSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2218715-B1 | PHOTOACID GENERATOR AND PHOTOREACTIVE COMPOSITION | SUMITOMO SEIKA CHEMICALS (JP) | 2017-06-28 | — | — | EP | disclosed |
| US-8216768-B2 | Photoacid generator and photoreactive composition | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100233621-A1 | PHOTOACID GENERATOR AND PHOTOREACTIVE COMPOSITION | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2010-09-16 | — | — | US | disclosed |
| EP-2218715-A1 | PHOTOACID GENERATOR AND PHOTOREACTIVE COMPOSITION | Sumitomo Seika Chemicals CO. LTD. (JP) | 2010-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233621-A1 | PHOTOACID GENERATOR AND PHOTOREACTIVE COMPOSITION | ARSA, SULT1A1, CYBA | FBP1 3147/4885PDE7A 4394/4885NPC1 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.